Human Metabolome Technologies, Inc. (6090.T)

JPY 604.0

(0.0%)

Total Liabilities Summary of Human Metabolome Technologies, Inc.

  • Human Metabolome Technologies, Inc.'s latest annual total liabilities in 2023 was 656.68 Million JPY , up 26.59% from previous year.
  • Human Metabolome Technologies, Inc.'s latest quarterly total liabilities in 2023 FY was 656.68 Million JPY , up 26.59% from previous quarter.
  • Human Metabolome Technologies, Inc. reported annual total liabilities of 518.73 Million JPY in 2022, down -10.89% from previous year.
  • Human Metabolome Technologies, Inc. reported annual total liabilities of 582.15 Million JPY in 2021, up 60.35% from previous year.
  • Human Metabolome Technologies, Inc. reported quarterly total liabilities of 656.68 Million JPY for 2023 Q4, up 16.26% from previous quarter.
  • Human Metabolome Technologies, Inc. reported quarterly total liabilities of 564.84 Million JPY for 2023 Q3, up 30.79% from previous quarter.

Annual Total Liabilities Chart of Human Metabolome Technologies, Inc. (2023 - 2019)

Historical Annual Total Liabilities of Human Metabolome Technologies, Inc. (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 656.68 Million JPY 26.59%
2022 518.73 Million JPY -10.89%
2021 582.15 Million JPY 60.35%
2020 363.04 Million JPY 12.44%
2019 322.88 Million JPY 0.0%

Peer Total Liabilities Comparison of Human Metabolome Technologies, Inc.

Name Total Liabilities Total Liabilities Difference
Shin Nippon Biomedical Laboratories, Ltd. 42.14 Billion JPY 98.442%
DNA Chip Research Inc. 250.12 Million JPY -162.546%
Cosmo Bio Company,Limited 1.84 Billion JPY 64.446%
H.U. Group Holdings, Inc. 152.84 Billion JPY 99.57%
FALCO HOLDINGS Co., Ltd. 10.39 Billion JPY 93.683%
BML, Inc. 40.85 Billion JPY 98.392%
Precision System Science Co., Ltd. 2.25 Billion JPY 70.862%